Kimberly-Clark Corporatio... (KMB)
NYSE: KMB
· Real-Time Price · USD
122.23
0.51 (0.42%)
At close: Sep 26, 2025, 3:59 PM
122.63
0.33%
After-hours: Sep 26, 2025, 07:56 PM EDT
Kimberly-Clark Revenue Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumer Tissue Revenue | 1.52B | 1.54B | 1.5B | 1.6B | 1.54B | 1.57B | 1.55B | 1.63B | 1.56B | 1.58B | 1.54B | 1.57B | 1.56B | 1.54B | 1.42B | 1.51B | 1.73B | 1.62B | 1.65B | 1.72B | 1.51B | 1.48B | 1.47B | 1.53B | 1.5B | 1.47B | 1.47B | 1.58B | 1.5B | 1.52B | 1.46B | 1.46B | 3B | 1.47B | 1.49B | 1.52B | 1.53B | 1.5B | 1.57B | 1.62B | 1.7B | 1.64B | 1.69B | 3.39B | 1.63B | 1.63B | 1.68B | 1.6B | 1.59B | 1.66B | 4.99B | 1.71B |
| Consumer Tissue Revenue Growth | -1.30% | +2.60% | -6.19% | +3.83% | -1.72% | +1.16% | -5.20% | +4.74% | -1.14% | +2.67% | -1.98% | +0.58% | +1.17% | +8.22% | -5.70% | -12.57% | +6.41% | -1.34% | -4.53% | +14.03% | +1.82% | +0.82% | -3.54% | +2.07% | +1.77% | -0.20% | -6.78% | +5.55% | -1.45% | +3.76% | +0.55% | -51.52% | +103.87% | -1.47% | -1.71% | -0.52% | +1.93% | -4.76% | -2.90% | -4.48% | +3.60% | -3.02% | -50.12% | +108.24% | +0.06% | -2.99% | +4.36% | +1.07% | -4.28% | -66.75% | +191.58% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 863M | 941M | 1.11B | 1.1B | 1.07B | 1.04B | 993M | 1.03B | 1.01B | 924M | 916M | 873M | 906M | 886M | 876M | 819M | 854M | 815M | 962M | 919M | 844M | 850M | 859M | 794M | 794M | 741M | 768M | 749M | 756M | 779M | 759M | 813M | 842M | 813M | 804M | 833M | 847M | 825M | 857M | 868M | 869M | 849M |
| Selling, General, and Administrative Revenue Growth | -8.29% | -15.15% | +1.09% | +2.91% | +2.60% | +4.63% | -3.50% | +1.38% | +9.85% | +0.87% | +4.93% | -3.64% | +2.26% | +1.14% | +6.96% | -4.10% | +4.79% | -15.28% | +4.68% | +8.89% | -0.71% | -1.05% | +8.19% | 0.00% | +7.15% | -3.52% | +2.54% | -0.93% | -2.95% | +2.64% | -6.64% | -3.44% | +3.57% | +1.12% | -3.48% | -1.65% | +2.67% | -3.73% | -1.27% | -0.12% | +2.36% | n/a |
| Research and Development Revenue | n/a | n/a | 338M | n/a | n/a | n/a | 312M | n/a | n/a | n/a | 292M | n/a | n/a | n/a | 269M | n/a | n/a | n/a | 276M | n/a | n/a | n/a | 284M | n/a | n/a | n/a | 317M | n/a | n/a | n/a | 309M | n/a | n/a | n/a | 328M | n/a | n/a | n/a | 324M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |